替诺福韦酯治疗慢性乙型肝炎的最新进展
在众多核苷和核苷酸类药物（NAs）中，替诺福韦（TDF）以其强效、低耐药性及对多种 NAs治疗失败的慢性乙型肝炎（CHB）患者有效的特点脱颖而出，使其在临床HBV感染治疗中被广泛应用。介绍了TDF对CHB初治患者和经治患者的疗效，并分析了其对肝硬化患者治疗的效果，同时也对TDF治疗的安全性进行了评估。认为TDF耐药率低、安全性好，为目前CHB治疗的一线药物。...
Saved in:
| Published in | 临床肝胆病杂志 Vol. 31; no. 4; pp. 599 - 602 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Chinese |
| Published |
吉林大学第一医院 肝胆胰内科,长春,130021%吉林大学第一医院 放射线科,长春,130021
2015
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1001-5256 |
| DOI | 10.3969/j.issn.1001-5256.2015.04.030 |
Cover
| Abstract | 在众多核苷和核苷酸类药物（NAs）中，替诺福韦（TDF）以其强效、低耐药性及对多种 NAs治疗失败的慢性乙型肝炎（CHB）患者有效的特点脱颖而出，使其在临床HBV感染治疗中被广泛应用。介绍了TDF对CHB初治患者和经治患者的疗效，并分析了其对肝硬化患者治疗的效果，同时也对TDF治疗的安全性进行了评估。认为TDF耐药率低、安全性好，为目前CHB治疗的一线药物。 |
|---|---|
| AbstractList | R512.62; 在众多核苷和核苷酸类药物（NAs）中，替诺福韦（TDF）以其强效、低耐药性及对多种 NAs治疗失败的慢性乙型肝炎（CHB）患者有效的特点脱颖而出，使其在临床HBV感染治疗中被广泛应用。介绍了TDF对CHB初治患者和经治患者的疗效，并分析了其对肝硬化患者治疗的效果，同时也对TDF治疗的安全性进行了评估。认为TDF耐药率低、安全性好，为目前CHB治疗的一线药物。 在众多核苷和核苷酸类药物（NAs）中，替诺福韦（TDF）以其强效、低耐药性及对多种 NAs治疗失败的慢性乙型肝炎（CHB）患者有效的特点脱颖而出，使其在临床HBV感染治疗中被广泛应用。介绍了TDF对CHB初治患者和经治患者的疗效，并分析了其对肝硬化患者治疗的效果，同时也对TDF治疗的安全性进行了评估。认为TDF耐药率低、安全性好，为目前CHB治疗的一线药物。 |
| Abstract_FL | There are 400 million individuals infected with chronic hepatitis B virus (HBV)all over the world.The management of chronic hepatitis B (CHB)has been improved markedly over the last decade,primarily due to the availability of oral nucleoside analogue (NA) therapy.Among the numerous NAs,tenofovir disoproxil fumarate (TDF)stands out for its high therapeutic efficacy,low drug resistance, and wide disease spectrum against several types of chronic CHB that can not be cured with NAs.Thus,TDF has been widely used for clinical treatment of chronic HBV infection.This paper describes the efficacy of TDF in nave and treated patients and analyzes its effect on cirrho-sis.Furthermore,the safety of TDF therapy is assessed.It is considered that TDF has low resistance rate and high safety,which provides a first-line drug for CHB treatment. |
| Author | 张悦 吕洋 李旭 高普均 |
| AuthorAffiliation | 吉林大学第一医院肝胆胰内科,长春130021 吉林大学第一医院放射线科,长春130021 |
| AuthorAffiliation_xml | – name: 吉林大学第一医院 肝胆胰内科,长春,130021%吉林大学第一医院 放射线科,长春,130021 |
| Author_xml | – sequence: 1 fullname: 张悦 吕洋 李旭 高普均 |
| BookMark | eNo9jz1LA0EYhLeIYIz5E2Jhc-d7u3fvsqUEvyBgk_7Y3cvFC3GjOURMFYKpBFMZ0fgBFrGM2qlF_oy5S_6FJxGrYYaHGWaF5EzTVAlZd8BmAsVm3Y7i2NgOgGN51EObguPZ4NrAIEfy__kyKcZxpMBzGArXwzzBZDiZjT_TUX_-NJr3xsn7Vzq4SXrPSefl--N2-ng56z6k3av07iK57ySD19lkOH27XiVLoWzE1eKfFkhlZ7tS2rPKB7v7pa2ypRGoJUMhAqmVDkKlApeCkJoqHgpOq5BZLimjoeToyQA55xqV4EA5lTKDAs4KZGNReyZNKE3NrzdPWyYb9Bu6Fqh2-_cnuFlXhq4tUH3YNLWTKIOPW9GRbJ37iC5HytBhP_7Raxc |
| ClassificationCodes | R512.62 |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
| DOI | 10.3969/j.issn.1001-5256.2015.04.030 |
| DatabaseName | 维普_期刊 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Latest progress in treatment of chronic hepatitis B with tenofovir disoproxil fumarate |
| DocumentTitle_FL | Latest progress in treatment of chronic hepatitis B with tenofovir disoproxil fumarate |
| EndPage | 602 |
| ExternalDocumentID | lcgdbzz201504042 664762361 |
| GroupedDBID | -05 2B. 2C~ 2RA 5XA 5XF 92F 92I 92L ABDBF ACGFS ALMA_UNASSIGNED_HOLDINGS CCEZO CIEJG CQIGP CW9 EAD EAP EOJEC ESX GROUPED_DOAJ IPNFZ OBODZ OK1 RIG RNS TCJ TGQ U1G U5O W91 ~WA 4A8 93N ABJNI ACUHS PSX |
| ID | FETCH-LOGICAL-c602-af99dacbcdfbbd4209ac2b7f972e04207a232fa765ad6777c6b970272aa7f9d73 |
| ISSN | 1001-5256 |
| IngestDate | Thu May 29 03:59:49 EDT 2025 Wed Feb 14 10:30:42 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | 肝炎,乙型,慢性 治疗结果 review 综述 tenofovir disoproxil fumarate 替诺福韦 hepatitis B,chronic treatment outcome |
| Language | Chinese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c602-af99dacbcdfbbd4209ac2b7f972e04207a232fa765ad6777c6b970272aa7f9d73 |
| Notes | There are 400 million individuals infected with chronic hepatitis B virus （HBV）all over the world.The management of chronic hepatitis B （CHB）has been improved markedly over the last decade,primarily due to the availability of oral nucleoside analogue （NA） therapy.Among the numerous NAs,tenofovir disoproxil fumarate （TDF）stands out for its high therapeutic efficacy,low drug resistance, and wide disease spectrum against several types of chronic CHB that can not be cured with NAs.Thus,TDF has been widely used for clinical treatment of chronic HBV infection.This paper describes the efficacy of TDF in nave and treated patients and analyzes its effect on cirrho-sis.Furthermore,the safety of TDF therapy is assessed.It is considered that TDF has low resistance rate and high safety,which provides a first-line drug for CHB treatment. hepatitis B,chronic; tenofovir disoproxil fumarate; treatment outcome; review ZHANG Yue,LYU Yang,LI Xu,et al（Department of Hepatology, The First Hospital of Jilin University, Changchun 1300 |
| PageCount | 4 |
| ParticipantIDs | wanfang_journals_lcgdbzz201504042 chongqing_primary_664762361 |
| PublicationCentury | 2000 |
| PublicationDate | 2015 |
| PublicationDateYYYYMMDD | 2015-01-01 |
| PublicationDate_xml | – year: 2015 text: 2015 |
| PublicationDecade | 2010 |
| PublicationTitle | 临床肝胆病杂志 |
| PublicationTitleAlternate | Chinese Journal of Clinical Hepatology |
| PublicationTitle_FL | Journal of Clinical Hepatology |
| PublicationYear | 2015 |
| Publisher | 吉林大学第一医院 肝胆胰内科,长春,130021%吉林大学第一医院 放射线科,长春,130021 |
| Publisher_xml | – name: 吉林大学第一医院 肝胆胰内科,长春,130021%吉林大学第一医院 放射线科,长春,130021 |
| SSID | ssib051369456 ssj0041983 ssib001103858 ssib053243598 ssib002264326 ssib038074677 |
| Score | 1.9800106 |
| Snippet | 在众多核苷和核苷酸类药物（NAs）中，替诺福韦（TDF）以其强效、低耐药性及对多种... R512.62; 在众多核苷和核苷酸类药物（NAs）中，替诺福韦（TDF）以其强效、低耐药性及对多种... |
| SourceID | wanfang chongqing |
| SourceType | Aggregation Database Publisher |
| StartPage | 599 |
| SubjectTerms | 乙型 慢性 替诺福韦 治疗结果 综述 肝炎 |
| Title | 替诺福韦酯治疗慢性乙型肝炎的最新进展 |
| URI | http://lib.cqvip.com/qk/90100X/201504/664762361.html https://d.wanfangdata.com.cn/periodical/lcgdbzz201504042 |
| Volume | 31 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR3LThRBsIOQEC_GZ0TUYEKfzOI8-jF9nN6dDTHBEybcNvPYgYNZfMBlT4TIyURPYhQfiQc8ot7UAz8ju_ANXqyqGXYHJQaNyWRS6Xp0d9VMd_VMVzVj00L6sUw9WVOindWEl8U1k_pJzZGx1io3yuQYnDx3R83eFbcX5MLIqR-VXUurK8lM2j02ruRfrAplYFeMkv0Lyw6EQgHAYF-4g4XhfiIb80hxY7lt8ijgYZPbkEeah4oHUGK4aSIMQCARC8TW49YijQFGjSWI8ghweAglgltgNDyS3EQ8sCg58LhpIBcAQUTsIQ8E1V5HRgRAuIPE0BhoErBblxcHWx76viQcCARhQUJYEQ6AzwNFwjW2CmU2EIvEIHMwX1JBnYdULeBDVcUYB2qlroKTbIeYQlpEAKioMcQYHlpuAsIAHJEUoNXVDyJFMCg9vGUtgSGOiPQIShSkPgAapHSoo45X0WfUkeRBnbRP-g29m8f1ngBbUJNxUBCoBOabOnGSMrBiMLiEQvxP6AFW_sdmAT-gSRHQFDS0RnthxSdqTWWiw6100iuSupfvuKhMZLI4tqr0iRRFxf823frwKtN0iyJnBiJxw6SkBMLlL7ejCc3vpYtZ0u0iEcwgAvynMU9rV46ysdA2bHPozbvOkVRLGPNdWW3gUQmiko1Rur4yYpgaSsJaAfNTHjpmwjVBEW9TtnOcTZeduPWnLmDWlaXlzuID8CUptK-Tx53Fihc6f5adKZePU2ExFpxjI92l82x8rtwgc4Gp3tbu_s7X_vazg3fbBxs7vc_f-psvehvve2sfvn95uff2yf76m_760_6rx73Xa73Nj_u7W3ufnl9k881ovj5bK49GqaVgi1qcG5PFaZJmeZJkwnNMnHqJzo322qBRR8ewUMpjrWScgYZ0qhKjHU97cQxEmfYvsdHOcqd9mU35Msgw2B7G8rZw43aSprnvpm6OI7UQ2QSbHPS-db_IgNNSSoAT5St3gt0o9dEqx8VHrV_te-UENJPsNMLFt82rbHTl4Wr7Gnj7K8n18qn4CSDauD4 |
| linkProvider | EBSCOhost |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%9B%BF%E8%AF%BA%E7%A6%8F%E9%9F%A6%E9%85%AF%E6%B2%BB%E7%96%97%E6%85%A2%E6%80%A7%E4%B9%99%E5%9E%8B%E8%82%9D%E7%82%8E%E7%9A%84%E6%9C%80%E6%96%B0%E8%BF%9B%E5%B1%95&rft.jtitle=%E4%B8%B4%E5%BA%8A%E8%82%9D%E8%83%86%E7%97%85%E6%9D%82%E5%BF%97&rft.au=%E5%BC%A0%E6%82%A6&rft.au=%E5%90%95%E6%B4%8B&rft.au=%E6%9D%8E%E6%97%AD&rft.au=%E9%AB%98%E6%99%AE%E5%9D%87&rft.date=2015&rft.pub=%E5%90%89%E6%9E%97%E5%A4%A7%E5%AD%A6%E7%AC%AC%E4%B8%80%E5%8C%BB%E9%99%A2+%E8%82%9D%E8%83%86%E8%83%B0%E5%86%85%E7%A7%91%2C%E9%95%BF%E6%98%A5%2C130021%25%E5%90%89%E6%9E%97%E5%A4%A7%E5%AD%A6%E7%AC%AC%E4%B8%80%E5%8C%BB%E9%99%A2+%E6%94%BE%E5%B0%84%E7%BA%BF%E7%A7%91%2C%E9%95%BF%E6%98%A5%2C130021&rft.issn=1001-5256&rft.issue=4&rft.spage=599&rft.epage=602&rft_id=info:doi/10.3969%2Fj.issn.1001-5256.2015.04.030&rft.externalDocID=lcgdbzz201504042 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F90100X%2F90100X.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Flcgdbzz%2Flcgdbzz.jpg |